A recent study detailed how drug decriminalization did not increase the risk of overdose-related deaths.
Conducted by Oregon and Washington, a recent study showed how drug decriminalization was not an instigator in overdose-related deaths (1). Drug policy reform has become a hot topic throughout the US. States such as Washington and Oregon have either fully or partially decriminalized drug possession. The study looked at an overview on overdose-related deaths, one-year post-implementation. Results showed that previous thoughts that the two may be connected were proven wrong.
In February 2021, Oregon enacted Measure 110. This showed that the state was suffering from a significant drug problem and that the state needed to expand access for drug treatment (2). Washington also experienced a State Supreme Court decision with the State v. Blake which stated that their felony drug possession law was considered unconstitutional (3).
MyCannabis mentioned that the study detailed (1):
Through the study’s findings, it shows the impact drug decriminalization can have on public health, as well as the need for further discussion on drug policy reform. An important note to take on this research is to remember that the data was only reviewing the short-term effects of decriminalization and that further investigation into the medium- and long-term effects needs to be explored. Drug reform advocates (1) are hopeful that research such as the study from Oregon and Washington, will bring about new data and legislation which will benefit those incarcerated, as well as public health.
References
Ep 25: Cannabis Quality Differentiation Beyond Cannabinoid Content
February 28th 2025In this latest installment of Noid Knowledge we are joined by Julie Kowalski, a leading mind in analytical chemistry and cannabis testing. Julie has arranged a very compelling symposium for Pittcon entitled Cannabis Aroma: Advances and Challenges in Determining and Commercializing Cannabis Product Quality Attributes. It is taking place on Wednesday, March 5, 2025, starting at 9:30 AM in room 209. The session features top notch speakers, including several previous guests of this show, and yours truly, discussing the next generation of quality assessment in cannabis.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 25: Cannabis Quality Differentiation Beyond Cannabinoid Content
February 28th 2025In this latest installment of Noid Knowledge we are joined by Julie Kowalski, a leading mind in analytical chemistry and cannabis testing. Julie has arranged a very compelling symposium for Pittcon entitled Cannabis Aroma: Advances and Challenges in Determining and Commercializing Cannabis Product Quality Attributes. It is taking place on Wednesday, March 5, 2025, starting at 9:30 AM in room 209. The session features top notch speakers, including several previous guests of this show, and yours truly, discussing the next generation of quality assessment in cannabis.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
2 Commerce Drive
Cranbury, NJ 08512